230 related articles for article (PubMed ID: 24362065)
1. Induction of WNT inhibitory factor 1 expression by Müllerian inhibiting substance/antiMullerian hormone in the Müllerian duct mesenchyme is linked to Müllerian duct regression.
Park JH; Tanaka Y; Arango NA; Zhang L; Benedict LA; Roh MI; Donahoe PK; Teixeira JM
Dev Biol; 2014 Feb; 386(1):227-36. PubMed ID: 24362065
[TBL] [Abstract][Full Text] [Related]
2. Focal Mullerian duct retention in male mice with constitutively activated beta-catenin expression in the Mullerian duct mesenchyme.
Tanwar PS; Zhang L; Tanaka Y; Taketo MM; Donahoe PK; Teixeira JM
Proc Natl Acad Sci U S A; 2010 Sep; 107(37):16142-7. PubMed ID: 20805501
[TBL] [Abstract][Full Text] [Related]
3. Müllerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Müllerian duct regression.
Zhan Y; Fujino A; MacLaughlin DT; Manganaro TF; Szotek PP; Arango NA; Teixeira J; Donahoe PK
Development; 2006 Jun; 133(12):2359-69. PubMed ID: 16687449
[TBL] [Abstract][Full Text] [Related]
4. Single-cell sequencing of neonatal uterus reveals an Misr2+ endometrial progenitor indispensable for fertility.
Saatcioglu HD; Kano M; Horn H; Zhang L; Samore W; Nagykery N; Meinsohn MC; Hyun M; Suliman R; Poulo J; Hsu J; Sacha C; Wang D; Gao G; Lage K; Oliva E; Morris Sabatini ME; Donahoe PK; Pépin D
Elife; 2019 Jun; 8():. PubMed ID: 31232694
[TBL] [Abstract][Full Text] [Related]
5. β-Catenin is essential for Müllerian duct regression during male sexual differentiation.
Kobayashi A; Stewart CA; Wang Y; Fujioka K; Thomas NC; Jamin SP; Behringer RR
Development; 2011 May; 138(10):1967-75. PubMed ID: 21490063
[TBL] [Abstract][Full Text] [Related]
6. Effect of human recombinant mullerian inhibiting substance on isolated epithelial and mesenchymal cells during mullerian duct regression in the rat.
Tsuji M; Shima H; Yonemura CY; Brody J; Donahoe PK; Cunha GR
Endocrinology; 1992 Sep; 131(3):1481-8. PubMed ID: 1505479
[TBL] [Abstract][Full Text] [Related]
7.
Mullen RD; Wang Y; Liu B; Moore EL; Behringer RR
Proc Natl Acad Sci U S A; 2018 Aug; 115(33):8382-8387. PubMed ID: 30061417
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of hormone-mediated Müllerian duct regression: involvement of beta-catenin.
Allard S; Adin P; Gouédard L; di Clemente N; Josso N; Orgebin-Crist MC; Picard JY; Xavier F
Development; 2000 Aug; 127(15):3349-60. PubMed ID: 10887090
[TBL] [Abstract][Full Text] [Related]
9. Involvement of a matrix metalloproteinase in MIS-induced cell death during urogenital development.
Roberts LM; Visser JA; Ingraham HA
Development; 2002 Mar; 129(6):1487-96. PubMed ID: 11880357
[TBL] [Abstract][Full Text] [Related]
10. Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.
Clarke TR; Hoshiya Y; Yi SE; Liu X; Lyons KM; Donahoe PK
Mol Endocrinol; 2001 Jun; 15(6):946-59. PubMed ID: 11376113
[TBL] [Abstract][Full Text] [Related]
11. Essential roles of mesenchyme-derived beta-catenin in mouse Müllerian duct morphogenesis.
Deutscher E; Hung-Chang Yao H
Dev Biol; 2007 Jul; 307(2):227-36. PubMed ID: 17532316
[TBL] [Abstract][Full Text] [Related]
12. The serine/threonine transmembrane receptor ALK2 mediates Müllerian inhibiting substance signaling.
Visser JA; Olaso R; Verhoef-Post M; Kramer P; Themmen AP; Ingraham HA
Mol Endocrinol; 2001 Jun; 15(6):936-45. PubMed ID: 11376112
[TBL] [Abstract][Full Text] [Related]
13. The müllerian inhibitor and mammalian sexual development.
Behringer RR
Philos Trans R Soc Lond B Biol Sci; 1995 Nov; 350(1333):285-8; discussion 289. PubMed ID: 8570693
[TBL] [Abstract][Full Text] [Related]
14. Functional redundancy of TGF-beta family type I receptors and receptor-Smads in mediating anti-Mullerian hormone-induced Mullerian duct regression in the mouse.
Orvis GD; Jamin SP; Kwan KM; Mishina Y; Kaartinen VM; Huang S; Roberts AB; Umans L; Huylebroeck D; Zwijsen A; Wang D; Martin JF; Behringer RR
Biol Reprod; 2008 Jun; 78(6):994-1001. PubMed ID: 18322278
[TBL] [Abstract][Full Text] [Related]
15. Genetic studies of MIS signalling in sexual development.
Jamin SP; Arango NA; Mishina Y; Behringer RR
Novartis Found Symp; 2002; 244():157-64; discussion 164-8, 203-6, 253-7. PubMed ID: 11990789
[TBL] [Abstract][Full Text] [Related]
16. The Müllerian inhibiting substance type 2 receptor suppresses tumorigenesis in testes with sustained β-catenin signaling.
Tanwar PS; Commandeur AE; Zhang L; Taketo MM; Teixeira JM
Carcinogenesis; 2012 Dec; 33(12):2351-61. PubMed ID: 22962306
[TBL] [Abstract][Full Text] [Related]
17. Paracrine-mediated apoptosis in reproductive tract development.
Roberts LM; Hirokawa Y; Nachtigal MW; Ingraham HA
Dev Biol; 1999 Apr; 208(1):110-22. PubMed ID: 10075845
[TBL] [Abstract][Full Text] [Related]
18. Anti-Müllerian hormone, beta-catenin and Müllerian duct regression.
Xavier F; Allard S
Mol Cell Endocrinol; 2003 Dec; 211(1-2):115-21. PubMed ID: 14656484
[TBL] [Abstract][Full Text] [Related]
19. The in vivo roles of müllerian-inhibiting substance.
Behringer RR
Curr Top Dev Biol; 1994; 29():171-87. PubMed ID: 7828438
[TBL] [Abstract][Full Text] [Related]
20. Sexually dimorphic development of the mammalian reproductive tract requires Wnt-7a.
Parr BA; McMahon AP
Nature; 1998 Oct; 395(6703):707-10. PubMed ID: 9790192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
